Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
4 buzzy new TV shows to watch — plus the return of 'The Comeback,' 'Jury Duty' and more - 2Ferrari Cavalcade Suspended After High-Speed Crash in Argentina Involving a Purosangue
- 3Desired Travel Objections Worldwide: Where to Go Straightaway
- 4Understanding the Rudiments of Tree Administrations
- 5The Best Portable Applications for Emotional wellness and Prosperity
- Chicago reports first rabies-positive dog in 61 years. What we know.
- The most effective method to Go with Informed Choices on Vehicle Leases
- 20-year-old who threatened German train attack remanded in custody
- Figure out How to Pick a Crematorium: Key Contemplations.
- Figure out How to Amplify the Resale Worth of Your Kona SUV
- Picking the Right Home Machines: A Commonsense Aide
- NASA releases new photos of interstellar comet 3I/ATLAS
- Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
- Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
